| Trade Names: | |
| Synonyms: | |
| Status: | Approved (1978) |
| Entry Type: | Small molecule |
| Molecule Category: | Salt |
| UNII: | 0WR771DJXV |
| Parent Compound: | DOBUTAMINE |
| InChI Key | BQKADKWNRWCIJL-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C18H24ClNO3 |
| Molecular Weight | 337.85 |
| AlogP | 2.96 |
| Hydrogen Bond Acceptor | 4.0 |
| Hydrogen Bond Donor | 4.0 |
| Number of Rotational Bond | 7.0 |
| Polar Surface Area | 72.72 |
| Molecular species | BASE |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 22.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| AGONIST | Beta-1 adrenergic receptor agonist | FDA |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 106 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Cardiovascular Diseases | 1 | D002318 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEBI | 4671 |
| ChEMBL | CHEMBL1200418 |
| FDA SRS | 0WR771DJXV |
| Guide to Pharmacology | 535 |
| KEGG | C06967 |
| PubChem | 65324 |
| SureChEMBL | SCHEMBL41609 |
| ZINC | ZINC00057278 |